US Patent 10006032 Predictive biomarker for cancer therapy
Patent 10006032 was granted and assigned to Mologen AG on June, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10006032 Predictive biomarker for cancer therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
